Comparative efficacy of the use of different etiotropic therapies of urogenital clamidiosis during the second half of pregnancy period
https://doi.org/10.20538/1682-0363-2004-4-38-43
Abstract
Analysis of pregnancy course, labor and early neonatal period at 294 women and their new-born children has been made for the estimation of the efficacy of different antibacterial therapy variants of urogenital clamidiosis during the second half of pregnancy period. The danger of abortion and chronic intrauterine fetal hypoxia are most often gestational process complications revealed against chronic urogenital clamidiosis. The use of sumamed is course dose of 3 g is an optimum pharmacotherapeutic regimen during the second half of pregnancy period.
About the Authors
S. S. Antonova
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
S. Yu. Yuryev
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
S. A. Rostova
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
T. V. Gabidulina
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
N. N. Goncharova
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
I. D. Yevtushenko
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
L. I. Kokh
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
References
1. Анастасьева В.Г., Нехорошкова Е.Н., Коваленко Н.В. Синдром задержки внутриутробного развития плода у жительниц г. Новосибирска // Вестн. перинатол., акушерства и гинекол. 2003. С. 4—11.
2. Кулаков В.И. Развитие перинатального акушерства (проблемы и решения) // Материалы IV Рос. форума «Мать и дитя»: Тезисы докладов. М., 2002. С. 6—8.
3. Berman S.M., Harrison H.R., Boyce W.T. et al. Low birth weight, prematurity and postpartum endometritis. Association with prenatal cervical Mycoplasma hominis and Chlamydia trachomatis infections // JAMA. 1987. V. 257. P. 1189—1194.
4. Caldwell H.D., Kromhout J., Schachter J. Purification and characterization of the major outer membrane protein of Chlamydia trachomatis // Infect. Immun. 1981. V. 31. P. 1161—1176.
5. Claman P., Toye B., Peeling R.W. et al. Serologic evidence of Chlamydia trachomatis infection and risk of preterm birth // Can. Med. Assoc. J. 1995. V. 153. № 3. P. 259—262.
6. Goldenberg R.L., Rouse D.J. Prevention of premature birth // N. Engl. J. Med. 1998. V. 339. № 28. P. 313—320.
7. Harrison H.R., Alexander E.R., Weinstein L. et al. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes // JAMA. 1983. V. 250. P. 1721—1727.
8. Hillier S.L., Nugent R.P., Eschebach D.A. et al. Klebanoff for the Vaginal Infections and Prematurity Study Group Association between bacterial vaginosis and preterm delivery of a low birth-weight infant // N. Engl. J. Med. 1995. V. 333. № 26. P. 1737—1742.
9. Martin D.H., Eschebach D.A., Daling J.R. et al. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections // JAMA 1982. V. 247. P. 1585—1599.
10. Philip A.G.S. Neonatal mortality rate: is further improvement possible? // J. Pediatr. 1995. V. 126. № 3. P. 427—433.
11. Rae R., Smith I.W., Liston W.A. et al. Chlamydial serologic studies and recurrent spontaneous abortion // Am. J. Obstet. Gynecol. 1994. V. 170. № 3. P. 782— 785.
12. Romero R., Mazor M. Infection and preterm labor // Clin. Obstet. Gynecol. 1988. V. 31. P. 553—584.
Review
For citations:
Antonova S.S., Yuryev S.Yu., Rostova S.A., Gabidulina T.V., Goncharova N.N., Yevtushenko I.D., Kokh L.I. Comparative efficacy of the use of different etiotropic therapies of urogenital clamidiosis during the second half of pregnancy period. Bulletin of Siberian Medicine. 2004;3(4):38-43. (In Russ.) https://doi.org/10.20538/1682-0363-2004-4-38-43
Views:
633
Email this article 